FAQs Essentially yes
One study has also indicated that GLP-1RAs can be utilized in the treatment of skeletal muscle atrophy in diabetic patients with chronic liver disease (CLD) (24)
i) Optical density (O.D., absorbance) was recorded using a microtiter plate reader (Tecan, Switzerland) at max 490 nm using a 620 nm filter as a reference wavelength
Safety data for lipotropic formulations in pregnancy and breastfeeding is lacking
Rather than focusing solely on calorie counting, aim for a diet rich in: Lean proteins (chicken, fish, legumes, eggs) which support satiety and help preserve muscle mass during weight loss, which is particularly important given that GLP-1-based therapies may reduce lean mass alongside fat if protein intake is insufficient Fibre-rich vegetables and wholegrains which slow gastric emptying and complement the drug's appetite-suppressing effects Healthy fats (olive oil, avocado, nuts) in moderate quantities to support hormonal health Minimally processed foods reducing reliance on ultra-processed products that are engineered to override satiety signals If you have chronic kidney disease or other conditions affecting protein metabolism, speak to your clinical team before significantly increasing protein intake
Retatrutide produced 28.7% body weight loss at 68 weeks in Phase 3 trials